Funds managed by CapMan will invest EUR 1.4m in Swedish medtech company QuickCool AB, a developer of a new method to prevent brain damage by cooling of the brain. CapMan Life Science IV Fund will have a 25% stake in the company. The majority of the remaining shares are held by the company’s management and founders together with Swedish venture capital investor TeknoSeed AB.
Fund invests equity tickets in the range of €200m-1bn in North American and European companies
Freight service makes its second bolt-on of 2020, having acquired Nova Traffic in May
Clinics will operate under MVZ Meine Gynäkologie Lüdenscheid, a Meine Radiologie Holding subsidiary
GP is deploying capital from its second fund, which closed in 2017 on €600m